Inspections, Compliance, Enforcement, and Criminal Investigations
Facet Technologies, LLC - Close Out Letter 10/27/11
| Public Health Service Food and Drug Administration |
Atlanta District Office |
October 27, 2011
VIA UPS
Kevin Seifert, CEO
Facet Technologies, LLC
112 Town Park Drive
Suite 300
Kennesaw, GA 30144
Dear Mr. Seifert:
The Food and Drug Administration has completed an evaluation of your corrective actions in response to our Warning Letter# 11-ATL-09, dated May 19, 2011. Based on our evaluation, it appears that you have addressed the violations contained in the warning letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely,
/s/
Lakisha N. Morton
Compliance Officer
Atlanta District
Cc:
Howard Baker, Vice President of Quality & Regulatory Affairs
Facet Technologies, LLC
112 Town Park Drive
Suite 300
Kennesaw, GA 30144





Department of Health and Human Services

